Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
Natural killer (NK) cells are key players in human innate immunity. Cell engager antibody formats that recruit and activate NK cells more effectively have emerged as a promising immunotherapy approach to target cancer cells through more effective antibody-dependent cell-mediated cytotoxicity (ADCC)....
Saved in:
| Main Authors: | Bill Liao, Christine Tumanut, Lin Li, Adam Corper, Dilip Challa, Alex Chang, Hydari Begum, Elinaz Farokhi, Catherine Woods, Xiaomin Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2381261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
by: Kerry A. Whalen, et al.
Published: (2023-12-01) -
Trispecific SEED antibodies engineered for neutrophil-mediated cell killing
by: Veronica Natale, et al.
Published: (2025-12-01) -
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01) -
Influence of CD16 (FcγRIII) Expression on Peripheral Blood Mononuclear Cells on Response to Treatment with Rituximab in Pemphigus: A Cross-Sectional Study
by: Ankur Sharma, et al.
Published: (2025-07-01) -
Avelumab induces greater Fc-Fc receptor-dependent natural killer cell activation and dendritic cell crosstalk compared to durvalumab
by: Nicole Osborne, et al.
Published: (2025-12-01)